• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用序贯生物发光共振能量转移技术检测涉及多巴胺受体的受体异聚体。

Detection of receptor heteromers involving dopamine receptors by the sequential BRET-FRET technology.

作者信息

Navarro Gemma, McCormick Peter J, Mallol Josefa, Lluís Carme, Franco Rafael, Cortés Antoni, Casadó Vicent, Canela Enric I, Ferré Sergi

机构信息

Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain.

出版信息

Methods Mol Biol. 2013;964:95-105. doi: 10.1007/978-1-62703-251-3_7.

DOI:10.1007/978-1-62703-251-3_7
PMID:23296780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9386282/
Abstract

Until very recently, dopamine receptors, like other G-protein-coupled receptors, were believed to function as individual units on the cell surface. Now it has been described by several groups including ours that dopamine receptors not only function as homomers but also form heteromers with other receptors at the membrane level. Bioluminescence and fluorescence resonance energy transfer (BRET and FRET) based techniques have been very useful to determine the interaction between two receptors, but to demonstrate the existence of higher-order complexes involving more than two molecules requires more sophisticated techniques. Combining BRET and FRET in the Sequential BRET-FRET (SRET) technique permits heteromers formed by three different proteins to be identified. In SRET experiments, the oxidation of a Renilla Luciferase substrate triggers acceptor excitation by BRET and subsequent energy transfer to a FRET acceptor. Using this methodology here we describe the heteromerization between adenosine A(2A), dopamine D(2), and cannabinoids CB(1) receptors in living cells.

摘要

直到最近,多巴胺受体与其他G蛋白偶联受体一样,被认为在细胞表面作为单个单元发挥作用。现在,包括我们小组在内的几个研究团队已经表明,多巴胺受体不仅以同聚体的形式发挥作用,还能在膜水平与其他受体形成异聚体。基于生物发光和荧光共振能量转移(BRET和FRET)的技术对于确定两个受体之间的相互作用非常有用,但要证明涉及两个以上分子的高阶复合物的存在则需要更复杂的技术。在顺序BRET-FRET(SRET)技术中结合BRET和FRET,可以识别由三种不同蛋白质形成的异聚体。在SRET实验中,海肾荧光素酶底物的氧化通过BRET触发受体激发,随后能量转移到FRET受体。在这里,我们使用这种方法描述了活细胞中腺苷A(2A)、多巴胺D(2)和大麻素CB(1)受体之间的异聚化。

相似文献

1
Detection of receptor heteromers involving dopamine receptors by the sequential BRET-FRET technology.采用序贯生物发光共振能量转移技术检测涉及多巴胺受体的受体异聚体。
Methods Mol Biol. 2013;964:95-105. doi: 10.1007/978-1-62703-251-3_7.
2
Detection of heteromerization of more than two proteins by sequential BRET-FRET.通过连续生物发光共振能量转移(BRET)-荧光共振能量转移(FRET)检测两种以上蛋白质的异源二聚化
Nat Methods. 2008 Aug;5(8):727-33. doi: 10.1038/nmeth.1229. Epub 2008 Jun 29.
3
Monitoring Opioid Receptor Interaction in Living Cells by Bioluminescence Resonance Energy Transfer (BRET).利用生物发光共振能量转移(BRET)监测活细胞中的阿片受体相互作用。
Methods Mol Biol. 2021;2201:35-43. doi: 10.1007/978-1-0716-0884-5_4.
4
A biophysical approach for the study of dopamine receptor oligomerization.一种用于研究多巴胺受体寡聚化的生物物理方法。
Methods Mol Biol. 2013;964:79-94. doi: 10.1007/978-1-62703-251-3_6.
5
Combining SRET and BiFC to Study GPCR Heteromerization and Protein-Protein Interactions.结合单分子分辨率能量转移(SRET)和双分子荧光互补(BiFC)技术研究G蛋白偶联受体(GPCR)异源二聚化及蛋白质-蛋白质相互作用
Methods Mol Biol. 2019;1947:199-215. doi: 10.1007/978-1-4939-9121-1_11.
6
Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays.利用分子间生物发光共振能量转移测定法鉴定趋化因子(C-X-C 基元)受体 4 与 α-肾上腺素能受体之间的异源二聚体复合物。
Biochem Biophys Res Commun. 2020 Jul 23;528(2):368-375. doi: 10.1016/j.bbrc.2020.02.094. Epub 2020 Feb 19.
7
Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes.用于研究G蛋白偶联受体-受体酪氨酸激酶异源受体复合物的生物发光共振能量转移方法。
Methods Cell Biol. 2013;117:141-64. doi: 10.1016/B978-0-12-408143-7.00008-6.
8
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors.钙调蛋白、腺苷A2A受体与多巴胺D2受体之间的相互作用。
J Biol Chem. 2009 Oct 9;284(41):28058-28068. doi: 10.1074/jbc.M109.034231. Epub 2009 Jul 24.
9
Monitoring opioid receptor dimerization in living cells by bioluminescence resonance energy transfer (BRET).通过生物发光共振能量转移(BRET)监测活细胞中的阿片受体二聚化。
Methods Mol Biol. 2015;1230:105-13. doi: 10.1007/978-1-4939-1708-2_8.
10
Bioluminescence resonance energy transfer-based imaging of protein-protein interactions in living cells.基于生物发光共振能量转移的活细胞内蛋白质-蛋白质相互作用的成像。
Nat Protoc. 2019 Apr;14(4):1084-1107. doi: 10.1038/s41596-019-0129-7. Epub 2019 Mar 25.

引用本文的文献

1
mFusion: a multiscale fusion method bridging neuroimages to genes through neurotransmissions in mental health disorders.mFusion:一种通过心理健康障碍中的神经传递将神经影像与基因联系起来的多尺度融合方法。
Commun Biol. 2024 Dec 25;7(1):1699. doi: 10.1038/s42003-024-07404-x.
2
Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.阿尔茨海默病中的多巴胺与多巴胺受体:系统评价与网状Meta分析
Front Aging Neurosci. 2019 Jul 11;11:175. doi: 10.3389/fnagi.2019.00175. eCollection 2019.

本文引用的文献

1
G protein-coupled receptor heteromers as new targets for drug development.G 蛋白偶联受体异源二聚体作为药物开发的新靶点。
Prog Mol Biol Transl Sci. 2010;91:41-52. doi: 10.1016/S1877-1173(10)91002-8.
2
Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer.G 蛋白偶联受体同型二聚体作为中枢神经系统疾病治疗靶点的黄金时期:多巴胺 D₁-D₃ 受体同型二聚体。
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):596-600. doi: 10.2174/187152710793361603.
3
GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers?
G 蛋白偶联受体同型二聚体和异型二聚体:作为药物开发靶点是否优于 G 蛋白偶联受体单体?
Pharmacol Ther. 2009 Nov;124(2):248-57. doi: 10.1016/j.pharmthera.2009.07.005. Epub 2009 Aug 5.
4
Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.多巴胺A类G蛋白偶联受体二聚体原聚体之间的变构通讯调节激活。
Nat Chem Biol. 2009 Sep;5(9):688-95. doi: 10.1038/nchembio.199. Epub 2009 Aug 2.
5
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.多巴胺D1受体与组胺H3受体异聚化后信号转导的显著变化。
Br J Pharmacol. 2009 May;157(1):64-75. doi: 10.1111/j.1476-5381.2009.00152.x.
6
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells.代谢型谷氨酸5型、多巴胺D2型和腺苷A2a受体在活细胞中形成高阶寡聚体。
J Neurochem. 2009 Jun;109(5):1497-507. doi: 10.1111/j.1471-4159.2009.06078.x. Epub 2009 Mar 30.
7
Building a new conceptual framework for receptor heteromers.构建受体异聚体的新概念框架。
Nat Chem Biol. 2009 Mar;5(3):131-4. doi: 10.1038/nchembio0309-131.
8
Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.多巴胺D5受体和D5-D2受体异源寡聚体的钙信号传导机制不同于多巴胺D1-D2受体异源寡聚体的机制。
Mol Pharmacol. 2009 Apr;75(4):843-54. doi: 10.1124/mol.108.051805. Epub 2009 Jan 26.
9
Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.通过结合双分子荧光互补和生物发光能量转移检测大麻素CB1、多巴胺D2和腺苷A2A G蛋白偶联受体形成的异源二聚体。
ScientificWorldJournal. 2008 Oct 11;8:1088-97. doi: 10.1100/tsw.2008.136.
10
Dopamine D2 receptors form higher order oligomers at physiological expression levels.多巴胺D2受体在生理表达水平上形成高阶寡聚体。
EMBO J. 2008 Sep 3;27(17):2293-304. doi: 10.1038/emboj.2008.153.